Menopause and Dry Skin: What Actually Causes It, What Actually Works, and What the FDA Has Already Ruled On

Menopause and dry skin are genuinely connected: falling estrogen is associated with changes in the outer barrier’s ceramides. But the “30% collagen loss” number measures a deeper layer than the one that feels dry. HRT is not FDA-approved for body or facial dryness, and pooled clinical studies did not show a statistically significant dryness benefit.

Best for you if: your skin changed in your 40s or 50s, it feels tight, rough, papery or flaky, and the products that worked for years suddenly do nothing.

Not for you if: you have a rash that will not settle, skin that is cracked, bleeding, weeping or looks infected, a changing or bleeding spot, or dryness alongside strong thirst, frequent urination and unexplained weight loss. Those need a person, not a moisturiser. Skip to the red-flag section below.

Start here: find your situation

If this sounds like you	Your most useful next step
Dry, tight or flaky; worse in cold or dry weather; no rash	Change three things tonight — see What should you do tonight?
It started after a new medicine or dose change	Build a medication timeline before you buy anything else
Dry skin plus feeling cold, exhausted, constipated or noticing hair thinning	Take the whole cluster to primary care; no single symptom can diagnose thyroid disease
Itchy or scaly patches keep returning in the same places	Treat this as a possible skin condition, not automatically “menopause dryness”
Dryness includes vulvar or vaginal soreness, burning or pain with sex	Take the GSM lane — that tissue has FDA-approved hormone options
Correct gentle care is not clearly helping, or everything stings	Stop escalating products and get the skin assessed

The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.

Here is what makes this page different. We do not sell skincare, supplements or hormones. We opened the federal regulations covering hormone creams, current U.S. prescribing labels, and the studies repeatedly used to sell menopausal skin products.

What we found is sharper than the usual “estrogen falls, so buy more moisture” story. The FDA has a specific rule for over-the-counter hormone creams. Prescription ammonium lactate has an approved indication for xerosis. And the pooled hormone-therapy evidence shows a split that most summaries blur: collagen, thickness and elasticity improved; dryness did not.

This page does not recommend a skincare brand or tell you to start HRT for your skin. Two clearly labeled care-routing links appear near the end. We may earn a commission from them, but the evidence and the disqualifiers come first.

---

When is dry skin not just dry skin?

Most midlife dryness can start with gentle barrier care. A persistent rash, broken or infected-looking skin, a changing lesion, whole-body symptoms or atypical vulvar changes need assessment instead. The point of this list is not to make ordinary winter dryness frightening. It is to stop the wrong problem being treated with another bottle.

Get seen promptly if you have:

• Skin that is broken, weeping, crusting, increasingly warm, swollen or painful, or looks infected
• A new or changing patch or spot, especially one that changes size, shape or colour, or repeatedly itches or bleeds
• Dryness with strong thirst, frequent urination and unintended weight loss
• Widespread scaling that appeared quickly when you have never had it before
• Dry skin plus persistent dry eyes and dry mouth, particularly with joint or systemic symptoms
• Vulvar skin that is thickened, whitened, persistently itchy, split or bleeding rather than simply feeling dry
• Symptoms that are disrupting sleep or daily life and are not improving with a stable gentle routine

Get emergency help for trouble breathing or rapid swelling of the face, lips, tongue or throat.

And the part nobody prints: dryness that is worse in winter, worse on the shins, worse after a hot shower, or that flares and settles is not an emergency by itself. This is not a complete diagnostic list and it is not a reason to panic. It is a filter.

---

Menopause and dry skin: can menopause actually cause it?

Yes. Menopause is a plausible contributor because the outer skin barrier changes as estrogen falls, but menopause is not a diagnosis for every dry patch. Age, eczema, weather, medicines and systemic conditions can produce the same feeling, which is why the pattern and timing matter more than the word “menopause.”

What actually changes in the skin barrier?

A 2022 Scientific Reports study examined the stratum corneum — the outermost barrier — in three small groups: seven women before menopause, eleven after menopause without hormone therapy, and ten after menopause while using hormone therapy.^[1]

Researchers used tape stripping and lipid analysis. Postmenopausal skin without hormone therapy had changes in its ceramide profile, including shorter ceramides; shorter ceramides correlated with greater transepidermal water loss. Ceramides are one class of fatty molecule that helps seal the spaces between surface skin cells. Think of the barrier as a brick wall: cells are the bricks, and lipids including ceramides help form the mortar.

The study also found relationships between circulating estradiol and parts of the ceramide profile, and estradiol increased selected ceramides in cultured human keratinocytes. The hormone-therapy group did not show the same pattern of ceramide loss as the untreated postmenopausal group.^[1]

The limits, because they are real: the groups contained 7, 11 and 10 women; all participants were White; hormone therapy was not randomly assigned; and this was a mechanism study, not a trial showing that HRT treats dry skin. The project was supported by The No7 Beauty Company and Boots UK alongside public research funding, and two authors were affiliated with The No7 Beauty Company. That does not erase the data. It does belong next to the data.^[1]

But the practical connection survives those limits. Ceramides in moisturisers belong to the same class of barrier lipid the study found altered after menopause. That is a biologically coherent reason to consider them. It is not proof that any product with “ceramide” on the front will outperform a well-formulated cream or ointment.

How common is dry skin in this age group?

The strongest population number on this page comes from the Rotterdam Study. In 5,547 adults aged 51 to 101, clinicians graded skin as not dry, locally dry or generally dry. Sixty percent had dry skin, and one in five of those cases was generalized. The rest was localized to the extensor sides of the extremities — the outward-facing areas that include common trouble spots such as shins and outer forearms.^[2]

That answers a question almost nobody addresses: why my shins? Because dry skin often clusters on exposed extensor surfaces. You are not imagining a strange pattern.

The factors significantly associated with both localized and generalized dry skin were age, female sex, skin colour, body mass index, outside temperature, eczema and past chemotherapy. The cross-sectional design cannot prove what caused what, and menopausal status was not reported as one of the modelled determinants.^[2]

Two co-authors were affiliated with Unilever Research and Development. We are flagging that because commercial affiliations matter on a topic crowded with moisturiser marketing. The study is still unusually useful: it is large, population-based and physician-graded rather than a survey asking people whether they felt dry.^[2]

The clean conclusion is not “60% of women have menopausal dry skin.” It is this: dry skin is common in the same age band, women were more likely to have it, and lower outside temperature mattered — but that study does not isolate menopause as the cause.

---

Why does the “30% collagen loss” number not explain dry skin?

The famous number may describe a real early postmenopausal change in dermal collagen, but it is routinely used to explain a surface-barrier symptom it did not measure. Collagen sits mainly in the dermis. Tightness after washing, flaking and dusty-looking shins are primarily stratum-corneum problems one layer above.

We followed the citation trail instead of repeating the number

The source chain is less tidy than the certainty of the marketing suggests.

Source in the chain	What it actually says	What it does not establish
Brincat and colleagues, 1985	Skin collagen declined with postmenopausal age in the study population	The abstract does not give the familiar “30% in five years” line
Brincat and colleagues, 1987	The abstract reports skin collagen content and thickness declining about 1% to 2% per year after menopause	It does not report “30% in five years” in the abstract
Later review literature	Reviews repeat an estimate of about 30% collagen loss in the first five postmenopausal years	A review estimate is not a direct measure of hydration, xerosis or barrier repair
Current consumer and clinic pages	The number is often presented as the explanation for dryness	Repetition does not turn a dermal statistic into an epidermal outcome

The 1985 paper found that skin collagen declined with years since menopause in untreated women, but its abstract does not state the familiar 30% estimate.^[27] The 1987 paper most often named in the chain is Brincat and colleagues in Obstetrics & Gynecology. Its abstract reports that skin collagen content, skin thickness and bone measures declined between 1% and 2% per year after menopause.^[3] A 2005 review by Brincat and colleagues repeats the larger early-loss estimate as something that had been suggested.^[4]

We are not calling the 30% number false. We are making a narrower, more useful claim: even a perfectly accurate collagen estimate would still be the wrong evidence for why your shins feel dry tonight.

The part that actually matters: it is the wrong layer

Your skin has layers that do different jobs.

• The dermis is deeper. It contains most of the skin’s collagen and contributes to thickness, strength and elasticity — how skin holds its structure.
• The epidermis is above it. Its outermost layer, the stratum corneum, limits water loss and governs much of how dry skin feels at the surface.

Collagen loss can help explain thinner, less elastic, crepey skin. It does not directly explain every episode of tightness after cleansing, flaking or itch. Those point first toward the surface barrier.

Nearly every page on this topic uses a structural-protein statistic to explain a hydration symptom. That is why a “collagen-boosting” serum can make a defensible claim about appearance and still fail to fix the thing you actually noticed.

The pooled HRT evidence exposes the split

In 2023, Pivazyan and colleagues published a systematic review and meta-analysis of menopausal hormone therapy and skin. They screened 1,526 records and included 15 clinical studies covering 1,589 women.^[5]

Skin outcome	What it mostly reflects	Pooled result	Statistically significant?
Collagen content	Dermal structure	SMD 2.01 (95% CI 1.42 to 2.61), P < 0.00001	Yes
Skin thickness	Structural thickness	SMD 1.27 (95% CI 0.88 to 1.66), P < 0.00001	Yes
Skin elasticity	Biomechanical behaviour	SMD 0.28 (95% CI 0.03 to 0.54), P = 0.03	Yes
Skin dryness	Surface symptom	SMD 0.15 (95% CI −0.05 to 0.35), P = 0.14	No

SMD means standardised mean difference, used when studies measure an outcome on different scales. For the dryness result, the confidence interval crossed zero, so the pooled estimate could not be distinguished from no effect.

Three structural or biomechanical outcomes moved. Dryness did not. The authors also noted limitations including moderate risk of bias and non-standardized measurement methods, so this is not a perfect final answer. It is still the most direct pooled answer available to the question people keep using collagen statistics to avoid.^[5]

The paper’s conclusion emphasised elasticity, collagen, wrinkles and thickness. The non-significant dryness result is in the analysis, even though it is not the headline most pages repeat.

If you take one thing from this page, take this: the deep layer and the surface layer are different problems. They may coexist. They do not automatically respond to the same thing.

You do not have to turn one skin symptom into an HRT decision by yourself

The right online HRT provider is not the same for every woman — it depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state. Some situations belong with an in-person clinician first. Because a general answer cannot resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider — and to flag when online care is not the right starting point — before your first consult. → Get my personalised HRT starting-point plan About 90 seconds. No email is needed, and the live tool states that answers are not stored or sent off the page.

---

What does menopausal dry skin actually feel like?

Common descriptions include tightness after washing, rough or powdery texture, recurring flakes, itch, makeup catching and products that suddenly sting. Those sensations fit dry or irritated skin, but they do not prove menopause caused it. A persistent rash, oozing, bleeding, marked pain or whole-body itch belongs in a different lane.

Readers usually do not say “my transepidermal water loss increased.” They say things like:

Paper-like. Dusty or ashy. Moisturiser sitting on top. Makeup catching by midday. The same lotion suddenly doing nothing. Products that never bothered me now burning.

That last shift deserves a straight answer: your moisturiser may not have changed. The wall it was working on did. A light lotion that felt adequate on an intact barrier can feel useless once the barrier holds water less effectively.

How does it show up in different places?

Face and neck. Tightness after cleansing, rough texture, flaking around the nose or brows, makeup catching, and acids or retinoids suddenly burning. Rosacea, seborrhoeic dermatitis and contact irritation can overlap with this picture and need different treatment.

Arms, legs and torso. Ashy or scaly-looking skin, though how that appears varies by skin tone. Itch after bathing. Shins and outer extremities are common sites, consistent with the localized pattern in the Rotterdam data.^[2]

Hands. Cracking around fingertips and knuckles, made worse by repeated washing, cleaning products and cold weather. Hands often need moisturiser after washing rather than once at bedtime.

Scalp. A flaky or itchy scalp is often not simple xerosis. Seborrhoeic dermatitis, psoriasis and reactions to dye or hair products can look similar. Treat scalp symptoms as their own question rather than rubbing body moisturiser into them.

Dry and spotty at once. Dryness and adult acne can coexist. Stripping harder usually makes the barrier side of that problem worse.

---

What should you do tonight for menopausal dry skin?

Start with three changes: a short warm—not hot—wash, gentle fragrance-free cleanser only where you need it, and a cream or ointment applied while skin is still damp. Dermatology guidance consistently puts bathing habits and product format before a hunt for exotic ingredients.^[6]

The three-step version

1. Wash briefly and warm, not hot. Keep showers or baths around five to ten minutes. Hot water and long washing can worsen dryness.^[6]
2. Pat instead of rubbing, and stop while the skin is still slightly damp. Do not scrub the water off.
3. Apply a fragrance-free cream or ointment promptly. You are sealing in water already on the skin, not waiting for the skin to dry and trying to add it back later.^[6]

That is it. If you do nothing else on this page, do those three consistently before buying another active.

Why does format matter more than the front-label ingredient?

Format	What it is like	Where it tends to fit
Lotion	Light, higher water content	Mild dryness, humid weather, hairy or large areas where heavier products feel impractical
Cream	Thicker balance of water and oil	The default starting point for moderate body or facial dryness
Ointment	Greasier, more occlusive, little water	Very dry patches, hands, feet and overnight use
Balm	Dense, usually for a small area	Lips, cuticles and cracked fingertips

Creams and ointments generally hold water better than lotions, which is why dermatologists often prefer them for genuinely dry skin.^[6] A thin formula with a fashionable ingredient can lose to a thick, boring formula you will actually apply.

Which ingredients appear in the FDA’s OTC skin-protectant rule?

The FDA’s OTC skin-protectant regulation lists active ingredients and concentration ranges for products making specific drug claims, including temporary protection or relief of chapped or cracked skin and protection from the drying effects of wind and cold. It is a regulatory list, not a “best moisturiser” ranking and not proof that cosmetics without a Drug Facts panel are ineffective.^[7]

Selected skin-protectant active	Permitted concentration in 21 CFR Part 347	Practical role in a formula
Petrolatum or white petrolatum	30% to 100%	Strong occlusion; reduces water escape
Mineral oil	50% to 100%	Occlusive/emollient
Dimethicone	1% to 30%	Barrier film with a less greasy feel
Glycerin	20% to 45%	Humectant within an OTC skin-protectant drug formula
Lanolin	12.5% to 50%	Occlusive/emollient; can trigger allergy or irritation in some people
Colloidal oatmeal	0.007% minimum	Skin protectant; the rule also permits certain minor-irritation and itch claims
Allantoin	0.5% to 2%	Skin protectant
Cocoa butter	50% to 100%	Occlusive/emollient

A product regulated as an OTC drug will carry a Drug Facts panel. A cosmetic moisturiser may still be useful without one; it simply is not making the same regulated drug claim. Do not dismiss a good cream because its ingredient percentage is not printed or because it is sold as a cosmetic rather than an OTC drug.

Two other ingredients are worth separating from that federal list:

• Ceramides are barrier lipids. The menopause study above gives them a specific biological rationale, but product performance still depends on the whole formula and how consistently you use it.^[1]
• Hyaluronic acid is a humectant. A light hyaluronic-acid serum may feel insufficient on very dry skin because it does not provide much occlusion by itself. Put it under a cream or choose a complete moisturiser rather than expecting the serum alone to act like an ointment.

Is “fragrance-free” different from “unscented”?

Yes. “Unscented” can mean fragrance was used to mask the smell of other ingredients. “Fragrance-free” is the more useful label when you are trying to remove a common source of irritation. The American Academy of Dermatology makes that distinction directly.^[8]

It is not a guarantee that nothing will irritate you. It is simply a cleaner first filter than “natural,” “clean,” “anti-ageing” or “for mature skin.”

Will drinking more water fix dry skin?

If you are normally hydrated, extra water is unlikely to repair a leaky outer barrier by itself. Stay normally hydrated for your general health. Do not let a skincare page turn a surface-barrier problem into a gallon-a-day challenge.

Strong thirst, frequent urination and unintended weight loss are different. That cluster is one of the reasons to contact primary care rather than simply drinking more and moisturising harder.

---

What should you stop using while your skin is unhappy?

Pause products that sting, burn or visibly worsen the area, and simplify long enough to learn what your skin tolerates. Fragrance, scrubs, strong acids, retinoids and repeated cleansing can be difficult on an already disrupted barrier. This is a temporary reset, not a declaration that every active is bad forever.

The pause list: physical scrubs and cleansing brushes · strong AHAs and BHAs on the irritated area · retinol or prescription retinoid on skin that is actively raw unless your prescriber directs otherwise · fragranced skincare and essential oils · deodorant soap · alcohol-heavy toner · very hot water · repeated washing · several new products at once.

If a clinician prescribed a retinoid or medicated cream, ask before stopping or changing it. Do not make a permanent medication decision from an article.

Why does scrubbing the flakes off make it worse?

This is the loop people get stuck in:

1. You see flakes.
2. You exfoliate to remove them.
3. Friction or acid adds more irritation.
4. The barrier sheds and stings more.
5. The flakes return, so you exfoliate again.

Exfoliation is not always wrong. But when visible flakes are coming from an unhappy barrier, aggressive exfoliation treats the evidence by worsening the conditions that created it.

Why does your moisturiser sting now?

Stinging can happen when a disrupted barrier lets ingredients reach living tissue and nerve endings more easily. It is not proof the product is “working.”

Stop the product that reliably stings. Go bland. Once the skin is comfortable, reintroduce one product at a time. If nearly everything burns, or the burning persists even with a simple fragrance-free cream or ointment, get the skin looked at instead of making a seventh purchase.

---

How do you run a 14-day barrier reset?

Use two weeks as a controlled editorial checkpoint: simplify, repeat the same basic care and record whether tightness, itch, sting and flaking move. Fourteen days is not a guaranteed healing deadline or a clinical cutoff. It is long enough to stop changing five variables at once and start learning from the pattern.

Day 0: record the baseline

Note where the dryness is. Rate tightness, itch and sting from 0 to 10. List your cleanser, moisturiser, actives, hair products, laundry products, supplements and medicines. Mark anything that started or changed recently. Check for rash, cracks, bleeding, oozing, swelling or sleep disruption. Take a photo in consistent light if that would help you compare later.

Days 1 to 3: remove the stress

Use short warm showers. Cleanse only where needed. Pat to damp. Apply a fragrance-free cream or ointment promptly. Reapply to hands after washing. Pause the irritation list. Keep sunscreen if your skin tolerates it.

Days 4 to 7: repeat instead of escalating

Change nothing unless a product is making you worse. Run a humidifier if indoor air is very dry. Record whether tightness, itch, sting and flaking are better, the same or worse.

Days 8 to 14: decide what the result means

Clearly improving? Keep the simple routine. Reintroduce optional actives one at a time after the skin is comfortable, not all on the same Monday.

Still stinging, a rash has appeared, cracks are deepening, or you are worse? Stop buying and book an appointment. Whole-body clues showing up? Take the cluster to primary care. Vulvar or vaginal symptoms? Use the separate GSM lane below.

Track it, or it does not count

Date	Area	Tight /10	Itch /10	Sting /10	Rash, cracks or bleeding?	Products used	Shower time and temperature	Medicine/product change?	Better, same or worse?

Two weeks is a test. Make it a test that tells you something.

Screenshot or print the tracker. If your skin change sits alongside hot flashes, night sweats, cycle changes, painful sex or other menopause symptoms, use Find My HRT Path to see which care route fits your full situation — and when online care should not be the starting point.

---

Is it menopause, or could something else be causing the dryness?

Menopause is a plausible contributor, not a diagnosis. Thyroid disease, eczema, contact reactions, diabetes, autoimmune dryness, infection and medicines can produce a similar surface symptom. The fastest way out of the buying loop is to route the pattern before choosing another product.

What you are noticing	What it raises	What menopause can and cannot explain	First step	Track this
Diffuse tightness and flaking, worse with cold or hot showers, no rash	Simple barrier dryness	Menopause can contribute; weather and washing can too	14-day reset	Weather, bathing and response
Started after a new medicine or dose change	Medication-related dryness	Menopause does not explain timing that follows a medication change	Build a timeline; speak to prescriber or pharmacist	Name, dose, date and before/after
Dry skin plus cold intolerance, fatigue, constipation or hair thinning	Thyroid disease	Menopause and thyroid disease share symptoms; the cluster needs assessment	Primary care	The whole cluster
Itchy or scaly patches recur in fixed places	Eczema, psoriasis or another dermatosis	Menopause does not identify the rash	Dermatology or primary care	Photos, sites and triggers
Stinging or burning started after a new skincare, hair or laundry product	Irritant or allergic contact dermatitis	Midlife skin may be less tolerant, but one new exposure is a stronger clue	Stop the suspect; simplify	Product and start date
Dryness plus thirst, frequent urination and weight loss	Diabetes or another systemic cause	Menopause does not explain that triad	Prompt primary care	All symptoms together
Dry skin plus persistent dry eyes and dry mouth, possibly joint symptoms	Autoimmune dryness, including Sjögren disease	Menopause can affect several tissues, but this pattern deserves assessment	Primary care	Which tissues and how long
Deep cracks, warmth, swelling, drainage or a wound not healing	Possible infection or impaired healing	Not a menopause self-care question	Prompt care; sooner with diabetes or immune suppression	Rate of change
Vulvar or vaginal dryness, burning, pain with sex or urinary symptoms	GSM or another vulvovaginal condition	Menopause commonly causes GSM, but atypical skin changes need examination	See the GSM section	Symptom location and timing

This is a routing aid, not a diagnosis. More than one thing can be true at once. Menopause can alter the barrier while eczema, a new cleanser or a medicine adds a second hit.

Could it be your thyroid?

This is the row we most want you to read.

In a population-based case-control study of hypothyroidism symptoms, people with an underactive thyroid most often reported tiredness (81%), dry skin (63%) and shortness of breath (51%). But of 34 symptoms examined, only 13 were significantly more common in hypothyroidism, and no single symptom could identify the condition by itself.^[9]

So dry skin is common in hypothyroidism and useless as a stand-alone test at the same time. The cluster is what matters.

A European Menopause and Andropause Society position statement notes that thyroid disease and menopause share symptoms and that subclinical hypothyroidism affects roughly 6% to 10% of women, commonly from autoimmune disease. The practical problem is not that every dry woman needs a thyroid test. It is that “dry skin, cold all the time, exhausted, constipated, hair thinning” should not be reduced to a moisturiser recommendation.^[10]

Bring the whole pattern. Your clinician decides which history, examination and tests fit it.

Could a medicine you already take be contributing?

Yes. The cleanest clue is timing: a symptom that begins after a new medicine or dose change deserves a medication review before a skincare shopping trip.

Here is one unusually relevant example. The Menopause Society’s 2023 nonhormone-therapy position statement includes oxybutynin among evidence-based nonhormonal options for vasomotor symptoms.^[11] Oxybutynin is an anticholinergic medicine originally labeled for bladder conditions, and dryness across several tissues appears in its current prescribing label.

Adverse reaction in overactive-bladder trials	Extended-release 5–30 mg/day	Immediate-release 5–20 mg/day
Dry mouth	34.9%	72.4%
Dry eye	3.1%	2.5%
Dry skin	1.8%	2.5%
Dry throat	1.7%	2.5%
Nasal dryness	1.7%	4.5%

Those percentages came from controlled overactive-bladder trials at the dose ranges shown. They are not a forecast of the risk when oxybutynin is used off-label for hot flashes, and they should not be carried across indications or doses as if they were.^[12]

What the table proves is narrower: a medicine used in menopause care can create a recognizable multi-tissue dryness pattern. That makes “what changed, and when?” a better question than “which menopause moisturiser should I buy?”

Never stop or alter a prescribed medicine because of this page. Take the timeline to the prescriber or pharmacist.

Build a timeline, not a list

A medicine list tells a clinician what you take. A timeline tells them what changed.

For each medicine, supplement or topical product, record:

1. Name
2. Dose or strength
3. Date started or changed
4. Time of day or frequency
5. What the skin and other tissues were like before and after

Five columns. Ten minutes. Much more useful than walking in with a bag of products and no dates.

If that matrix raised something you had not considered

Sort your broader menopause-care route with Find My HRT Path. It is an education and routing tool, not a diagnosis. It can point you toward a menopause provider, an alternative route or an in-person starting point based on the rest of your situation.

---

Does HRT help dry skin?

Not reliably enough to use HRT as a treatment for body or facial dryness. Menopausal hormone therapy is not FDA-approved for xerosis, and the 2023 pooled dryness result was not statistically significant. Some women may notice their skin feels better while using HRT, but that is a possible individual experience or incidental benefit, not an approved indication or a dependable reason to start therapy.^[5]

What do the clinical outcomes actually show?

Return to the pooled result: dryness SMD 0.15, 95% CI −0.05 to 0.35, P = 0.14. The confidence interval crossed zero. The same analysis found significant average improvements in collagen content, skin thickness and elasticity.^[5]

That split matters because it is exactly what the layer argument predicts: HRT may move some structural measures without producing a reliable dryness benefit.

A separate KEEPS skin ancillary study followed women aged 42 to 58 who were within three years of their last period and were randomized to oral conjugated estrogens, transdermal estradiol, or placebo; both active estrogen groups also received cyclic micronized progesterone. Over four years, investigators found no significant difference between the hormone groups and placebo in facial wrinkling or skin rigidity.^[13]

And here is the part that keeps the trial from answering your exact question: it measured wrinkles and rigidity, not xerosis, hydration or transepidermal water loss. It is evidence against an automatic anti-ageing effect in those measured outcomes. It is not a direct dry-skin trial.

How do you weigh the ceramide study against the pooled dryness result?

The Manchester study found a biologically specific barrier change and a more favourable ceramide profile in the small hormone-therapy group.^[1] The pooled clinical studies did not find a statistically significant dryness benefit.^[5]

Both findings are real. A small nonrandomized mechanism study tells you what could happen. Pooled clinical outcomes tell you what was observed across studies. When they point in different directions, the clinical outcome deserves more weight.

That does not close the research question forever. It means the current evidence does not justify selling HRT as a dry-skin treatment.

What did the FDA’s 2026 label changes change?

On November 10, 2025, the FDA requested major menopause-hormone-therapy labeling changes. Those included removing cardiovascular disease, breast cancer and probable dementia language from boxed warnings, removing the “lowest effective dose for the shortest amount of time” language, retaining the endometrial-cancer boxed warning for systemic estrogen-alone products, and keeping relevant cardiovascular and breast-cancer information elsewhere in systemic labels.^[14]

On February 12, 2026, the FDA approved updated prescribing information for the first six products. As of August 5, 2026, the FDA’s updated-product page lists Prometrium, Divigel, Cenestin, Enjuvia, Estring and Bijuva.^[15]

A current 2026 Enjuvia label, for example, lists moderate-to-severe vasomotor symptoms and moderate-to-severe vaginal dryness and pain with intercourse due to vulvar and vaginal atrophy. It does not list body or facial xerosis as an indication.^[16]

That absence is not proof HRT can never influence skin. It establishes the regulatory fact that the 2026 revisions did not create an approved body- or facial-dryness use.

For the full decision rather than the skin side question, see HRT benefits and risks.

---

Can you use estrogen cream on your face?

Do not repurpose an over-the-counter “hormone cream” or a prescription vaginal estrogen product as facial skincare on the strength of marketing or a social video. OTC topical hormone products sit under a specific federal rule, and vaginal products were formulated, dosed and studied for different tissue.

What does the federal OTC hormone-cream rule say?

21 CFR 310.530 is titled “Topically applied hormone-containing drug products for over-the-counter human use.” It states that estrogens, progesterone, pregnenolone and pregnenolone acetate have been marketed in topical OTC hormone creams, but that there is a lack of adequate data to establish effectiveness for any OTC drug use of those ingredients.^[17]

The rule continues:

• With the stated exception for hydrocortisone, an OTC product offered as a topical hormone cannot be considered generally recognized as safe and effective for its intended use.
• The word “hormone” in labeling or an ingredient statement implies a drug claim because it suggests a physiological or structural effect.
• A product presented that way requires the regulatory basis for a drug; it cannot avoid drug status by looking like skincare.^[17]

So an estrogen face cream sold over the counter is not sitting in a neutral beauty category the FDA has never considered. The regulation considered topical OTC hormone claims directly and found inadequate effectiveness data.

What does that rule not mean?

It does not govern prescription compounding. A pharmacy-compounded hormone cream made for an identified patient on a prescription sits in a different regulatory category. But the other critical fact remains: compounded drugs are not FDA-approved, and the FDA does not review them for safety, effectiveness or quality before marketing in the way it reviews approved drugs. Compounding can meet a legitimate patient need when an approved product cannot, but it must not be presented as FDA-approved or as automatically equivalent, safer or more natural.^[18]

It also does not mean no topical estrogen product is approved. FDA-approved prescription vaginal estrogen products exist for vulvovaginal indications. “Topical” does not make facial skin and vaginal tissue interchangeable.

What should you do with a vaginal estrogen cream?

Use it only as prescribed and labeled. Putting it on the face would be off-label use. Off-label prescribing can be medically legitimate, but it belongs to a prescriber who knows your history, the product, the dose, the proposed site and the evidence — not to an article converting “topical” into “put it anywhere.”

For the approved-tissue question, see vaginal estrogen.

---

What can a clinician prescribe for persistent dry, scaly skin?

There is an FDA-approved prescription option aimed at xerosis itself: ammonium lactate 12%. The current lotion label states that it is indicated for dry, scaly skin and ichthyosis vulgaris, with temporary relief of associated itch. It is a lactic-acid humectant and keratolytic, not a hormone.^[19]

The original Lac-Hydrin lotion was approved under NDA 19-155 on April 24, 1985, and prescription generic versions remain available.^[20]

What does the current lotion label actually say?

The label states that lactic acid may act as a humectant and may influence hydration of the stratum corneum. It may also reduce cohesion between surface cells.^[19]

For xerosis trials in that lotion label, the reported adverse reactions included:

• Transient stinging in about 1 in 30 patients
• Burning in about 1 in 30
• Redness in about 1 in 50
• Peeling in about 1 in 60

The label warns that stinging or burning can occur on fissured, eroded, abraded or freshly shaved skin; advises caution on the face; says to minimise or avoid sun exposure on treated areas; and says to avoid the eyes, lips and mucous membranes. The bottle label states that it is not for intravaginal use.^[19]

Those rates apply to the labeled lotion formulation and study population. Cream formulations can have different labeling and adverse-event rates, so do not merge them.

Ammonium lactate is not glamorous, and it is not the automatic next step for everyone. But after a correct barrier reset, “is a prescription xerosis treatment appropriate for this site?” is a more useful question than “which menopause serum is strongest?”

---

Is vaginal dryness the same as dry skin during menopause?

No. Vulvar and vaginal dryness involves different tissue and can be part of genitourinary syndrome of menopause, while dry skin on the face, arms or legs is xerosis. GSM has FDA-approved hormone treatments. Body and facial xerosis does not have an approved hormone indication.

This distinction changes the answer completely.

Body and facial dryness: start with barrier care, identify triggers and secondary causes, and consider a skin assessment or prescription xerosis treatment when needed.

Vulvar and vaginal dryness: may be part of genitourinary syndrome of menopause (GSM), which can include dryness, burning, pain with sex, urinary urgency and recurrent urinary discomfort. FDA-approved local vaginal estrogen products and other approved prescription options exist; nonhormonal vaginal moisturisers and lubricants are also useful, and they serve different purposes.^[26]

You can have both at once and need two different answers. That is not a contradiction.

Two rules keep the tissues straight:

1. Do not put body lotion inside the vagina.
2. Do not put vaginal estrogen on the face unless a prescriber has deliberately made and explained that off-label decision.

One more caution: vulvar skin that is whitened, thickened, persistently itchy, ulcerated, splitting or bleeding is not automatically GSM. Some vulvar skin conditions need examination and specific treatment. Do not let the word “dryness” erase the appearance of the tissue.

---

Do collagen supplements work for menopausal dry skin?

The evidence is conflicted, and neither of the two newest major reviews was specific to menopausal xerosis. A 2025 review found that pooled benefits disappeared in non-industry-funded and highest-quality subgroups; a 2026 updated analysis still found modest average improvements in measured hydration and barrier outcomes. That is not a clean yes or no.

What did the 2025 meta-analysis find?

Myung and Park reviewed 23 randomized trials with 1,474 participants. Across all studies, collagen supplements were associated with improvements in hydration, elasticity and wrinkles. But the benefit disappeared when the authors restricted analyses to trials without pharmaceutical-company funding, and it also disappeared in the highest-quality trials.^[21]

2025 analysis	Result
All 23 trials pooled	Significant average improvement in hydration, elasticity and wrinkles
Trials without pharmaceutical-company funding	No significant benefit
Industry-funded trials	Significant effects
Highest-quality trials	No significant effect

That funding pattern does not prove every positive trial is false. It does mean the headline effect is less secure than supplement advertising suggests.

What did the 2026 updated analysis add?

A 2026 systematic review and multilevel meta-analysis included 35 randomized trials with 2,534 participants. It reported statistically significant average improvements in instrument-measured hydration, elasticity and transepidermal water loss, with some outcomes appearing time-dependent. Some appearance and structural outcomes were less robust in sensitivity or multilevel analyses.^[22]

That newer analysis keeps the question open. It does not erase the funding and quality concerns raised in 2025, and it still does not establish collagen as a treatment for menopausal xerosis specifically.

What does that mean at the checkout button?

• Collagen supplements may produce modest changes in some measured skin outcomes for some people.
• The independent, highest-quality evidence is less convincing than the full pooled literature.
• The studies are not the same thing as a trial of women with menopause-related dry skin.
• A supplement is not a substitute for short warm washing, fragrance-free cream or ointment, trigger removal, and assessment when the pattern does not behave like simple xerosis.

The honest question is value, not whether every collagen peptide is useless. Do not buy it because someone used the “30% collagen” statistic to explain flaking. That statistic and that symptom are still on different floors.

---

Will menopausal dry skin go away?

Barrier symptoms often improve with consistent gentle care, but there is no universal two-week cure and no fixed date by which every case should be gone. Some people notice improvement within the 14-day checkpoint; persistent, recurrent or worsening dryness is information that the cause or treatment may be wrong.

What can improve: tightness, flaking, roughness, stinging and itch caused by a disrupted barrier. Consistent bathing changes and a cream or ointment can make a meaningful difference.^[6]

What may persist: thinner, less elastic or crepey skin associated with structural ageing. That is a different outcome from surface dryness.

What can come back: cold or dry weather can recreate the same barrier stress. The Rotterdam data identified outside temperature as a significant determinant of dry skin, so recurrence in colder conditions is plausible rather than proof that your routine “stopped working.”^[2]

Use the two-week reset as a learning checkpoint, not a promise. If the skin is clearly improving, keep going. If it is not, stop escalating products and move to diagnosis.

---

When should you see someone, and what should you bring?

See a dermatologist or primary-care clinician when dryness persists despite gentle care, forms a rash, keeps stinging, cracks, bleeds, oozes or comes with whole-body clues. Vulvar symptoms need their own route. The most useful thing you can bring is a timeline, not a bag of half-used moisturisers.

Who to see	When that route fits	What to bring
Dermatologist	Persistent rash, defined or recurring patches, severe facial sensitivity, repeated reactions, deep cracks, or no clear improvement with correct care	Photos of flares, product list, timeline, what you tried and what happened
Primary care	Widespread itch, fatigue-cold-constipation cluster, thirst and urination changes, weight change, dry eyes and mouth, medication questions	Full symptom cluster, medicine timeline and relevant history
Menopause clinician or gynaecology	Vulvar or vaginal symptoms, or a broader HRT decision	Menopause timeline, bleeding history, uterus status, symptoms and prior treatments
Prescriber or pharmacist	Dryness began after starting or changing a medicine	Exact medicine, dose, start date and other new symptoms
Prompt or urgent care	Rapidly worsening pain, warmth, swelling, drainage, infection signs or significant bleeding cracks	Medicine list, conditions and the rate of change

Four questions worth asking:

1. Does this look like simple xerosis or a specific skin condition?
2. Could a product or medicine be contributing?
3. Given the rest of my symptoms, is there another cause worth evaluating?
4. Which OTC ingredients or prescription options fit this body site?

“What counts as persistent?” means not clearly improving with a consistent gentle routine, repeatedly returning, or interfering with comfort, sleep, work or daily life. It is not one magic number of days.

If the skin itself needs looking at

Sesame currently lists virtual dermatology visits with upfront prices advertised as low as $34, with no insurance required. Exact prices, clinician type and appointment availability vary by location and time slot, and the amount shown before booking is the number that matters. A video visit cannot perform a biopsy or in-person procedure, so a changing lesion, suspicious spot or problem that needs hands-on examination may still require local in-person care.^[23] → See current dermatology availability and the price before booking Affiliate disclosure: We may earn a commission if you book through this link. Provider facts and advertised pricing were checked August 5, 2026.

---

When does online menopause care make sense for dry skin?

Most people reading this page do not need a menopause provider for their skin. Online menopause care becomes relevant when the dryness is one part of a broader menopause picture, when vulvar or vaginal symptoms need a GSM discussion, or when you want one clinician to review the menopause decision rather than treating a rash as a hormone problem.

Midi Health: the useful lane and the damaging admission

Midi does not replace dermatology. It cannot biopsy a changing patch, examine the whole skin surface in person or treat every rash through a screen. If the skin lesion itself is the main problem, choose dermatology or local in-person care.

That is the damaging admission. Here is the pivot: because Midi is a menopause-care service rather than a skincare seller, its relevant job is broader. A Midi clinician can review the menopause symptom picture and medication history, decide whether any testing or referral is appropriate, and discuss FDA-approved treatment when the problem includes GSM or another menopause indication. Midi currently states that it is available in all 50 states.^[24]

If your only symptom is dry shins, do not book a menopause consult for that. If the skin change sits inside a bigger menopause decision, that is the lane.

Provider-stated facts and what the live pages support

Verified August 5, 2026

Care route	Provider-stated fact	What the live page showed	The limit that matters
Sesame virtual dermatology	No insurance required; upfront prices; listings advertised as low as $34	The live dermatology page lists care for dry, red, itchy, scaly and cracked skin, eczema, psoriasis and rashes	Exact price and availability vary; virtual care cannot perform a biopsy or procedure
Midi menopause care	Available in all 50 states; self-pay $250 initial visit and $150 continued-care visit; in-network with most PPO plans	The live home and pricing pages; coverage language and exclusions	Coverage varies; no Medicaid or Medi-Cal patients even as self-pay; Medicare beneficiaries may self-pay but cannot submit related claims; Midi is not dermatology

Midi’s pricing page states that insurance patients pay their plan’s applicable copay and deductible; coverage varies by plan. It says Midi is not enrolled with Medicaid or Medi-Cal and cannot treat those patients even as self-pay. It also says Medicare beneficiaries may use self-pay but cannot submit claims for Midi visits, medications or associated services.^[25]

Does the broader menopause lane fit your situation? → Check Midi availability, coverage and your current visit cost Affiliate disclosure: We may earn a commission if you book through this link. The provider controls eligibility, coverage, pricing and treatment decisions.

Who are we not sending you to, and why?

We are not recommending a compounded-hormone provider for body or facial dryness.

This page’s argument depends on keeping approved indications, OTC hormone claims and compounding status separate. Walking you through that distinction and then handing you to a compounded topical hormone as the answer to xerosis would be incoherent.

Compounded drugs are not FDA-approved. The FDA does not evaluate them for safety, effectiveness or quality before marketing in the same way it reviews approved drugs. They can be appropriate when an FDA-approved product cannot meet an identified patient’s medical need. That is a clinician’s patient-specific compounding decision — not a reason to market a compounded face cream as equivalent to an approved menopause product.^[18]

We would rather lose the sale than lose the argument.

---

What did The HRT Index actually verify for this page?

We checked the federal rules, current prescribing labels, named studies and live provider pages behind the claims that could change a decision. We did not test moisturisers, diagnose readers, use first-person treatment experience or have the page medically reviewed. Where a study had commercial funding or affiliations, we disclosed it.

The evidence log

Claim readers may act on	Primary or authoritative source checked	Verified	What the source establishes	What it does not establish
Menopause changes the stratum-corneum ceramide profile	Kendall et al., Scientific Reports	Aug. 5, 2026	Small-group lipid findings, water-loss correlation, HRT-group pattern, funding and affiliations	That HRT treats clinical dryness
Dry skin prevalence and determinants in older adults	Mekić et al., JAAD	Aug. 5, 2026	5,547 participants, 60% prevalence, one-fifth generalized, associated factors	Menopause as an independently tested cause
HRT skin outcomes	Pivazyan et al., Journal of Menopausal Medicine	Aug. 5, 2026	Pooled collagen, thickness, elasticity and dryness estimates	A high-certainty dryness treatment effect
OTC skin-protectant ingredients and claims	21 CFR Part 347	Current through Aug. 3, 2026	Active ranges and permitted OTC drug claims	That every listed ingredient is superior to every cosmetic moisturiser
OTC topical hormone claims	21 CFR 310.530	Current through Aug. 3, 2026	Inadequate effectiveness data for OTC topical hormone drug uses and implied-drug-claim rule	The legality or appropriateness of a patient-specific prescription compound
Prescription xerosis treatment	Current ammonium lactate 12% lotion label and FDA NDA record	Aug. 5, 2026	Indication, directions, warnings and formulation-specific adverse-event rates	That it suits every site or every reader
2026 MHT label status	FDA updated-product page and 2026 Enjuvia label	Aug. 5, 2026	First six updated products and current approved indications	That HRT has no effect on any skin outcome
GSM treatment routes	The Menopause Society 2020 position statement	Aug. 5, 2026	FDA-approved local options and the roles of moisturisers and lubricants	That every vulvar symptom is GSM
Oxybutynin dryness rates	Current prescribing label	Aug. 5, 2026	Adverse-event rates in overactive-bladder trials at labeled dose ranges	Risk at a different off-label hot-flash dose
Collagen supplement evidence	2025 and 2026 systematic reviews	Aug. 5, 2026	Conflicting pooled and subgroup findings	A proven treatment for menopausal xerosis
Sesame dermatology facts	Live Sesame dermatology page	Aug. 5, 2026	Advertised price floor, direct pay and listed conditions	A guaranteed local slot, final price or in-person procedure
Midi cost and access	Live Midi home and pricing pages	Aug. 5, 2026	50-state access, self-pay prices, insurance language and exclusions	Your individual eligibility, coverage or treatment plan

How the provider research works

This page follows The HRT Index Verification Standard: read every published price, separate FDA-approved from compounded, verify state availability and insurance, and re-check on a fixed schedule, with top providers monthly and the full roster quarterly.

Provider research is organized around exactly five pillars, in this order: clinical legitimacy, care quality, medication fit, price transparency, access. We do not assign an invented numeric score to providers on this page.

What we did not do

We did not diagnose anyone, run a skincare trial, buy products, invent testimonials, add a fake medical reviewer or claim firsthand patient experience. This is editorial research, not medical advice, and it is not medically reviewed by a clinician.

---

Frequently asked questions

Can menopause cause dry skin?

Yes. Falling estrogen is associated with changes in the stratum-corneum ceramide profile and skin barrier, which gives menopause a plausible biological link to dryness.^[1] But weather, age, eczema, products, medicines and systemic conditions can create the same symptom, so “dry in my 40s” is not a diagnosis by itself.

Is dry skin an early sign of perimenopause?

It can appear during perimenopause, but it is nonspecific. Cycle changes, vasomotor symptoms, sleep disruption and the rest of the history provide more context. Do not start or reject hormone therapy on dry skin alone.

Does HRT help dry skin?

Not reliably. In the 2023 meta-analysis, HRT significantly improved average collagen content, thickness and elasticity, but the pooled dryness result was not statistically significant.^[5] HRT is not FDA-approved for body or facial xerosis.

Did the FDA’s 2026 hormone-label changes approve HRT for skin?

No. The changes revised safety labeling and current prescribing information for the first six products, but they did not add body or facial dry skin as an indication.^[14][15] Current labels still list specific menopause indications such as vasomotor symptoms and, for certain products, vulvovaginal symptoms or osteoporosis prevention.

Do over-the-counter estrogen face creams work?

The federal OTC topical-hormone rule says there is inadequate data to establish effectiveness for any OTC drug use of topical estrogens, progesterone, pregnenolone or pregnenolone acetate. It also treats “hormone cream” labeling as a drug claim.^[17]

Can I put vaginal estrogen cream on my face?

Not because an article or social video told you to. Vaginal estrogen is formulated, dosed and approved for vulvovaginal tissue. Facial use would be off-label and should only come from a prescriber making a deliberate, patient-specific decision.

What is the best moisturiser for menopausal dry skin?

There is no single best brand. Start with a fragrance-free cream or ointment rather than a light lotion, apply it promptly after a short warm wash, and choose a texture you will use consistently.^[6] Petrolatum, dimethicone, glycerin, mineral oil, colloidal oatmeal and ceramides are reasonable ingredients to recognise, but the whole formula matters.

Why does my moisturiser suddenly sting?

A disrupted or inflamed barrier can make previously tolerated ingredients burn. Stop the product that reliably stings, simplify the routine and reintroduce products one at a time after the skin is comfortable. If nearly everything stings, get the skin assessed.

Does drinking more water help dry skin?

Normal hydration supports general health, but drinking extra water is not a direct repair for a leaky outer barrier. Strong thirst with frequent urination and weight loss is not a skincare problem; take that cluster to primary care.

Do collagen supplements work for dry skin?

The evidence is mixed. The 2025 meta-analysis lost its apparent benefits in non-industry-funded and highest-quality subgroups, while a larger 2026 analysis found modest average improvements in measured hydration and barrier outcomes.^[21][22] Neither establishes collagen as a treatment for menopause-related xerosis.

Why is my dry skin worst on my shins and outer arms?

That is a common distribution. In the Rotterdam study, most people with dry skin had localized disease on the extensor sides of the extremities rather than generalized dry skin.^[2]

Could dry skin be my thyroid?

It is worth considering when dryness comes with cold intolerance, fatigue, constipation or hair changes. Dry skin was reported by 63% of people with hypothyroidism in one population study, but no symptom could diagnose the condition alone.^[9] Bring the full cluster to primary care.

Can a medicine cause dry skin?

Yes. Timing is the clue. If the problem began after a new prescription, dose change or topical product, record the date and take the timeline to the prescriber or pharmacist. Never stop a prescribed medicine on your own.

Will menopausal dry skin go away?

Barrier symptoms can improve substantially with consistent gentle care, but the timeline varies and recurrence in cold or dry weather is common. A rash, worsening cracks, repeated stinging or no clear improvement means it is time to reassess the diagnosis rather than keep buying.

Is dry skin the same as vaginal dryness in menopause?

No. Vulvar and vaginal dryness may be part of GSM and has FDA-approved hormone-treatment routes. Dry skin on the face, arms or legs is xerosis and has no approved hormone indication. You can have both at once and need two different answers.

---

What is the bottom line on menopause and dry skin?

Menopause can change the surface barrier, but collagen loss, body xerosis and vaginal dryness are not one interchangeable problem. Start with the barrier, route unusual patterns to the right clinician, and do not let a dermal statistic or a “hormone cream” label make the treatment decision for you.

• Dry skin and collagen loss sit in different layers. The pooled HRT evidence improved structural measures but not dryness.
• Use format before hype. A fragrance-free cream or ointment on damp skin after a short warm wash is the practical first move.
• Read the federal rule correctly. Part 347 regulates specific OTC skin-protectant ingredients and claims; it does not say every cosmetic without Drug Facts is useless.
• OTC hormone creams have their own rule. The FDA found inadequate effectiveness data for OTC topical hormone drug uses.
• Prescription ammonium lactate 12% is approved for xerosis. It can sting and has site and sunlight precautions, so it is a clinician/pharmacist conversation, not a blind upgrade.
• Check timing and symptom clusters. Thyroid clues, medicine changes, fixed rashes, dry eyes and mouth, diabetes symptoms and infection signs can change the route.
• Vulvar and vaginal dryness is a separate lane. GSM has approved hormone options; body and facial xerosis does not.

You were told your skin was dry because your collagen fell. It is a good story. It is just describing a different floor of the building.

---

Still not sure which HRT program is right for you? Take our free 90-second matching quiz.

→ Find My HRT Path — match your full situation to the most appropriate online care route and find out when online care is not the right starting point.

---

The HRT Index is reader-supported. We may earn a commission if you use the disclosed provider links on this page. That does not change the evidence, the disqualifiers or the fact that most readers do not need a menopause provider for ordinary dry skin. Educational content only — not medical advice, and not reviewed by a clinician.

---

Sources

¹ Kendall AC, Pilkington SM, Wray JR, et al. “Menopause induces changes to the stratum corneum ceramide profile, which are prevented by hormone replacement therapy.” Scientific Reports. 2022;12:22064. https://doi.org/10.1038/s41598-022-26095-0

² Mekić S, Jacobs LC, Gunn DA, et al. “Prevalence and determinants for xerosis cutis in the middle-aged and elderly population: A cross-sectional study.” Journal of the American Academy of Dermatology. 2019;81(4):963-969.e2. https://pubmed.ncbi.nlm.nih.gov/30586613/

³ Brincat M, Kabalan S, Studd JWW, et al. “A study of the decrease of skin collagen content, skin thickness, and bone mass in the postmenopausal woman.” Obstetrics & Gynecology. 1987;70(6):840-845. https://pubmed.ncbi.nlm.nih.gov/3120067/

⁴ Brincat MP, Baron YM, Galea R. “Estrogens and the skin.” Climacteric. 2005;8(2):110-123. https://doi.org/10.1080/13697130500118100

⁵ Pivazyan L, Avetisyan A, Loshkareva M, et al. “Effects of menopausal hormone therapy on skin aging: A systematic review and meta-analysis.” Journal of Menopausal Medicine. 2023;29(3):97-108. https://doi.org/10.6118/jmm.22042

⁶ American Academy of Dermatology. “Dermatologists’ top tips for relieving dry skin” and “Skin care in your 60s and 70s.” Accessed August 5, 2026. https://www.aad.org/public/everyday-care/skin-care-basics/dry/dermatologists-tips-relieve-dry-skin and https://www.aad.org/public/everyday-care/skin-care-basics/care/skin-care-in-your-60s-and-70s

⁷ Electronic Code of Federal Regulations. 21 CFR Part 347, “Skin Protectant Drug Products for Over-the-Counter Human Use,” including §§ 347.10 and 347.50. Current through August 3, 2026. https://www.ecfr.gov/current/title-21/chapter-I/subchapter-D/part-347

⁸ American Academy of Dermatology. “Dermatologists’ top tips for relieving dry skin,” including the fragrance-free versus unscented distinction. Accessed August 5, 2026. https://www.aad.org/public/everyday-care/skin-care-basics/dry/dermatologists-tips-relieve-dry-skin

⁹ Carlé A, Pedersen IB, Knudsen N, Perrild H, Ovesen L, Laurberg P. “Hypothyroid symptoms and the likelihood of overt thyroid failure: a population-based case-control study.” European Journal of Endocrinology. 2014;171(5):593-602. https://pubmed.ncbi.nlm.nih.gov/25305308/

¹⁰ European Menopause and Andropause Society. “Thyroid disease and menopause: A position statement.” 2024. https://emas-online.org/wp-content/uploads/2024/04/PIIS0378512224000860.pdf

¹¹ The Menopause Society. “The 2023 nonhormone therapy position statement of The North American Menopause Society.” Menopause. 2023;30(6):573-590. https://menopause.org/wp-content/uploads/professional/2023-nonhormone-therapy-position-statement.pdf

¹² DailyMed. Oxybutynin chloride extended-release tablets prescribing information, adverse-reaction table from controlled overactive-bladder trials. Revised January 2025; accessed August 5, 2026. https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=ada3be87-2cdd-75f7-e053-2995a90aa95b&type=display

¹³ Owen CM, Pal L, Mumford SL, et al. “Effects of hormones on skin wrinkles and rigidity in recently menopausal women: Results from the KEEPS skin ancillary study.” Fertility and Sterility. 2016;106(3):731-739.e1. https://pubmed.ncbi.nlm.nih.gov/27393520/

¹⁴ U.S. Food and Drug Administration. “FDA Requests Labeling Changes Related to Safety Information to Clarify the Benefit/Risk Considerations for Menopausal Hormone Therapies.” November 10, 2025. https://www.fda.gov/drugs/drug-alerts-and-statements/fda-requests-labeling-changes-related-safety-information-clarify-benefitrisk-considerations

¹⁵ U.S. Food and Drug Administration. “Menopausal Hormone Therapies with Updated Prescribing Information.” Accessed August 5, 2026. https://www.fda.gov/drugs/drug-safety-and-availability/menopausal-hormone-therapies-updated-prescribing-information

¹⁶ U.S. Food and Drug Administration. Enjuvia prescribing information, revised February 2026. https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/021443s014lbl.pdf

¹⁷ Electronic Code of Federal Regulations. 21 CFR 310.530, “Topically applied hormone-containing drug products for over-the-counter human use.” Current through August 3, 2026. https://www.ecfr.gov/current/title-21/chapter-I/subchapter-D/part-310/subpart-E/section-310.530

¹⁸ U.S. Food and Drug Administration. “Compounding and the FDA: Questions and Answers.” Accessed August 5, 2026. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers

¹⁹ DailyMed. Ammonium lactate lotion 12% prescribing information. Current label checked August 5, 2026. https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8bb09bb3-5bbc-489d-96c1-ae97cb58381e

²⁰ U.S. Food and Drug Administration. Chemistry review for ANDA 75-570, identifying Lac-Hydrin 12% lotion as NDA 19-155, approved April 24, 1985. https://www.accessdata.fda.gov/drugsatfdadocs/nda/2004/075570S000AMMONIUM%20LACTATECHEMR.pdf

²¹ Myung SK, Park Y. “Effects of Collagen Supplements on Skin Aging: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.” American Journal of Medicine. 2025. PMID 40324552. https://pubmed.ncbi.nlm.nih.gov/40324552/

²² Batool M, et al. “Oral Collagen Peptides and Skin Rejuvenation: A Systematic Review and Multilevel Meta-Analysis.” Journal of Cosmetic Dermatology. Published July 15, 2026. https://doi.org/10.1111/jocd.71041

²³ Sesame. “Book a virtual appointment with an online dermatologist.” Pricing and service details checked August 5, 2026. https://sesamecare.com/service/online-dermatology-consult-new-patient

²⁴ Midi Health. Home and care-access pages stating availability in all 50 states. Checked August 5, 2026. https://www.joinmidi.com/

²⁵ Midi Health. “Pricing & Insurance.” Self-pay and coverage details checked August 5, 2026. https://www.joinmidi.com/pricing-insurance

²⁶ The North American Menopause Society. “The 2020 genitourinary syndrome of menopause position statement.” Menopause. 2020;27(9):976-992. https://pubmed.ncbi.nlm.nih.gov/32852449/

²⁷ Brincat M, Moniz CJ, Studd JWW, Darby A, Magos A, Emburey G, Versi E. “Long-term effects of the menopause and sex hormones on skin thickness.” British Journal of Obstetrics and Gynaecology. 1985;92(3):256-259. https://pubmed.ncbi.nlm.nih.gov/3978054/